{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:47:08Z","timestamp":1786999628934,"version":"build-2736575974"},"reference-count":53,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>Outpatient diversion programs present an opportunity for severely mentally ill defendants to receive psychiatric treatment and have alleged offenses dismissed by the court. Moreover, the successful completion of pretrial diversion is associated with fewer post-program arrest and jail days. The target patient population for such programs is typically people with schizophrenia spectrum disorders, but the care of such patients in outpatient settings presents challenges for monitoring treatment fidelity, specifically antipsychotic adherence, as low adherence rates are associated with increased rates of recidivism. Presented here is a review of evidence-based strategies that must be employed to track antipsychotic adherence in outpatient diversion programs, including pill counts, use of long-acting injectable antipsychotics, and determination of plasma antipsychotic levels to assess adherence and the adequacy of antipsychotic treatment. Antipsychotic therapy remains the foundation of schizophrenia treatment, but only through the use of all available modalities can clinicians maximize the odds that schizophrenia patients in pretrial diversion maintain psychiatric stability and successfully complete mental health court mandates.<\/jats:p>","DOI":"10.1017\/s1092852919000865","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:58:45Z","timestamp":1558591125000},"page":"136-144","source":"Crossref","is-referenced-by-count":17,"title":["Monitoring and improving antipsychotic adherence in outpatient forensic diversion programs"],"prefix":"10.1017","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7294-4834","authenticated-orcid":false,"given":"Jonathan M.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"S1092852919000865_r4","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.134"},{"key":"S1092852919000865_r5","first-page":"20177917616","article-title":"Jail diversion for persons with serious mental illness coordinated by a Prosecutor\u2019s Office","author":"Gill","year":"2017","journal-title":"Biomed Res Int"},{"key":"S1092852919000865_r47","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1549489"},{"key":"S1092852919000865_r19","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08965"},{"key":"S1092852919000865_r42","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.49.4.347"},{"key":"S1092852919000865_r12","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31828568bc"},{"key":"S1092852919000865_r17","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbj075"},{"key":"S1092852919000865_r15","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115576688"},{"key":"S1092852919000865_r49","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13246"},{"key":"S1092852919000865_r24","volume-title":"Perseris Package Insert","year":"2018"},{"key":"S1092852919000865_r53","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145798001229"},{"key":"S1092852919000865_r10","doi-asserted-by":"publisher","DOI":"10.3371\/CSRP.ADRZ.121218"},{"key":"S1092852919000865_r46","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(95)00293-6"},{"key":"S1092852919000865_r13","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2007.58.6.844"},{"key":"S1092852919000865_r26","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0447-7"},{"key":"S1092852919000865_r25","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000691"},{"key":"S1092852919000865_r39","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31828b28d5"},{"key":"S1092852919000865_r50","first-page":"1618","article-title":"Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics","volume":"64","author":"Ereshefsky","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"S1092852919000865_r30","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12825"},{"key":"S1092852919000865_r52","first-page":"254","article-title":"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia","volume":"19","author":"Midha","year":"1994","journal-title":"J Psychiatry Neurosci."},{"key":"S1092852919000865_r34","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90165-4"},{"key":"S1092852919000865_r48","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1017"},{"key":"S1092852919000865_r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijlp.2018.05.001"},{"key":"S1092852919000865_r35","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05060gre"},{"key":"S1092852919000865_r23","volume-title":"Aristada Initio Package Insert","year":"2018"},{"key":"S1092852919000865_r44","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.06.041"},{"key":"S1092852919000865_r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.11.013"},{"key":"S1092852919000865_r27","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852913000783"},{"key":"S1092852919000865_r38","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(85)90063-0"},{"key":"S1092852919000865_r18","first-page":"201307","article-title":"Measuring adherence to antipsychotic medications for schizophrenia: concordance and validity among a community sample in rural China","author":"Xu","year":"2018","journal-title":"Schizophr Res."},{"key":"S1092852919000865_r21","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx090"},{"key":"S1092852919000865_r31","doi-asserted-by":"crossref","DOI":"10.1017\/9781108553575","volume-title":"The Clozapine Handbook","author":"Meyer","year":"2019"},{"key":"S1092852919000865_r20","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09584"},{"key":"S1092852919000865_r36","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000106221.36344.4d"},{"key":"S1092852919000865_r1","unstructured":"1. California Assembly Bill 1810. Pretrial Diversion, Section 15. 2018."},{"key":"S1092852919000865_r32","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852914000236"},{"key":"S1092852919000865_r16","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852917000840"},{"key":"S1092852919000865_r8","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx084"},{"key":"S1092852919000865_r40","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0209-9"},{"key":"S1092852919000865_r28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"S1092852919000865_r33","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31828ea95c"},{"key":"S1092852919000865_r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2017.07.006"},{"key":"S1092852919000865_r2","doi-asserted-by":"publisher","DOI":"10.1002\/bsl.883"},{"key":"S1092852919000865_r51","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.14101329"},{"key":"S1092852919000865_r14","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2007.58.9.1187"},{"key":"S1092852919000865_r37","first-page":"298","article-title":"A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy","volume":"57","author":"Wei","year":"1996","journal-title":"Journal of Clinical Psychiatry."},{"key":"S1092852919000865_r45","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.158.5.658"},{"key":"S1092852919000865_r43","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(10)70664-2"},{"key":"S1092852919000865_r22","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852917000840"},{"key":"S1092852919000865_r29","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04267"},{"key":"S1092852919000865_r6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201400230"},{"key":"S1092852919000865_r41","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1478727"},{"key":"S1092852919000865_r9","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2007.58.6.773"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852919000865","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T09:46:10Z","timestamp":1663494370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852919000865\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1092852919000865"],"URL":"https:\/\/doi.org\/10.1017\/s1092852919000865","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}